ES506669A0 - PROCEDURE FOR OBTAINING A NEW COMPOUND DERIVED FROM P-CHLOROPHENOXYACETIC ACID - Google Patents

PROCEDURE FOR OBTAINING A NEW COMPOUND DERIVED FROM P-CHLOROPHENOXYACETIC ACID

Info

Publication number
ES506669A0
ES506669A0 ES506669A ES506669A ES506669A0 ES 506669 A0 ES506669 A0 ES 506669A0 ES 506669 A ES506669 A ES 506669A ES 506669 A ES506669 A ES 506669A ES 506669 A0 ES506669 A0 ES 506669A0
Authority
ES
Spain
Prior art keywords
new compound
compound derived
chlorophenoxyacetic acid
procedure
obtaining
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES506669A
Other languages
Spanish (es)
Other versions
ES8206435A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sociedad Espanola de Especialidades Farmaco Terapeuticas SA
Original Assignee
Sociedad Espanola de Especialidades Farmaco Terapeuticas SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sociedad Espanola de Especialidades Farmaco Terapeuticas SA filed Critical Sociedad Espanola de Especialidades Farmaco Terapeuticas SA
Priority to ES506669A priority Critical patent/ES506669A0/en
Publication of ES8206435A1 publication Critical patent/ES8206435A1/en
Publication of ES506669A0 publication Critical patent/ES506669A0/en
Priority to JP57188907A priority patent/JPS5883662A/en
Priority to US06/436,960 priority patent/US4476319A/en
Priority to EP82109995A priority patent/EP0078518B1/en
Priority to DE8282109995T priority patent/DE3262166D1/en
Priority to AT82109995T priority patent/ATE11530T1/en
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C213/00—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C213/06—Preparation of compounds containing amino and hydroxy, amino and etherified hydroxy or amino and esterified hydroxy groups bound to the same carbon skeleton from hydroxy amines by reactions involving the etherification or esterification of hydroxy groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
    • C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C219/06—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having the hydroxy groups esterified by carboxylic acids having the esterifying carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00—Systems containing at least three condensed rings
    • C07C2603/56—Ring systems containing bridged rings
    • C07C2603/58—Ring systems containing bridged rings containing three rings
    • C07C2603/70—Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74—Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

A new compound derived from p-chlorophenoxyacetic acid, the p-chlorophenoxyacetate of 1-aminoadamantine-2-ethanol of the following structural formula I: <IMAGE> I as well as its pharmaceutically acceptable salts, possessing properties for the treatment of various pathological conditions of the central nervous system. Also disclosed are its method of preparation; pharmaceutical compositions containing the said compounds; and the treatment of various pathological conditions of the central nervous system with the use of the said compositions.
ES506669A 1981-10-29 1981-10-29 PROCEDURE FOR OBTAINING A NEW COMPOUND DERIVED FROM P-CHLOROPHENOXYACETIC ACID Granted ES506669A0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
ES506669A ES506669A0 (en) 1981-10-29 1981-10-29 PROCEDURE FOR OBTAINING A NEW COMPOUND DERIVED FROM P-CHLOROPHENOXYACETIC ACID
JP57188907A JPS5883662A (en) 1981-10-29 1982-10-26 P-chlorophenoxyacetic acid derivative, manufacture and central nervous dysfunction inproving agent
US06/436,960 US4476319A (en) 1981-10-29 1982-10-27 P-Chlorophenoxyacetic acid derivative, its method of preparation, the pharmaceutical compositions containing it and its use in medicine
EP82109995A EP0078518B1 (en) 1981-10-29 1982-10-28 A new p-chlorophenoxyacetic acid derivative, its method of preparation and pharmaceutical composition
DE8282109995T DE3262166D1 (en) 1981-10-29 1982-10-28 A new p-chlorophenoxyacetic acid derivative, its method of preparation and pharmaceutical composition
AT82109995T ATE11530T1 (en) 1981-10-29 1982-10-28 P-CHLOROPHENOXYACETIC ACID DERIVATIVE, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ES506669A ES506669A0 (en) 1981-10-29 1981-10-29 PROCEDURE FOR OBTAINING A NEW COMPOUND DERIVED FROM P-CHLOROPHENOXYACETIC ACID

Publications (2)

Publication Number Publication Date
ES8206435A1 ES8206435A1 (en) 1982-08-16
ES506669A0 true ES506669A0 (en) 1982-08-16

Family

ID=8483149

Family Applications (1)

Application Number Title Priority Date Filing Date
ES506669A Granted ES506669A0 (en) 1981-10-29 1981-10-29 PROCEDURE FOR OBTAINING A NEW COMPOUND DERIVED FROM P-CHLOROPHENOXYACETIC ACID

Country Status (6)

Country Link
US (1) US4476319A (en)
EP (1) EP0078518B1 (en)
JP (1) JPS5883662A (en)
AT (1) ATE11530T1 (en)
DE (1) DE3262166D1 (en)
ES (1) ES506669A0 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0870757T3 (en) * 1997-04-10 2002-07-15 Pfizer Fluorine-substituted adamantane derivatives
EP4366722A1 (en) * 2021-07-08 2024-05-15 NLS Pharmaceutics AG Melafenoxate and derivatives thereof for use in treating circadian rhythm sleep disorders with or without neurodegenerative diseases

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2628973A (en) * 1951-02-24 1953-02-17 Searle & Co Aryloxyacetates of basically substituted arylakanols and derivatives thereof
NL6410363A (en) * 1964-09-05 1966-03-07
US3546273A (en) * 1967-06-01 1970-12-08 Merck & Co Inc Ester derivatives of 2-(4-halophenoxy)alkanoic acids
JPS5019542A (en) * 1973-06-20 1975-03-01
JPS5135896B2 (en) * 1973-06-20 1976-10-05

Also Published As

Publication number Publication date
EP0078518A1 (en) 1983-05-11
ES8206435A1 (en) 1982-08-16
ATE11530T1 (en) 1985-02-15
EP0078518B1 (en) 1985-01-30
DE3262166D1 (en) 1985-03-14
US4476319A (en) 1984-10-09
JPS632542B2 (en) 1988-01-19
JPS5883662A (en) 1983-05-19

Similar Documents

Publication Publication Date Title
NZ191867A (en) N1,n1,2,3,4,5,6-substituted-1-piperazine-carboxamides and carbothioamides
ES8609303A1 (en) A 6-fluoro-1,4-dihydro-4-oxo-7-substituted piperazinyl-quinoline-3-carboxylic acid derivative and the method for preparing the same.
ES498502A0 (en) A PROCEDURE FOR THE PREPARATION OF DERIVATIVES OF THE AZETIDINEACETIC ACID.
PT76495A (en) Process for preparing new imidazolphenyl-tetrahydropyridazines
ES524680A0 (en) PROCEDURE FOR OBTAINING NEW COMPOUNDS DERIVED FROM DIPHENYL-METHYLENE-ETHYLAMINE.
ES554305A0 (en) PROCEDURE FOR THE MANUFACTURE OF QUINOLYL GLYCINAMIDES
ES490379A0 (en) PROCEDURE FOR THE PREPARATION OF NEW INDIVIDUAL DERIVATIVES
ES8501763A1 (en) Novel derivative of thienopyridinone, its preparation and its therapeutic use.
ES543805A0 (en) PROCEDURE FOR THE PREPARATION OF NEW A-ETILBEN-ZOL DERIVATIVES WITH A SUBSTITUTED DIALKYLAMINOALCOXY GROUP AND ITS ADDITIONAL SAILS FOR QUATERNARY AMONICS AND ACIDES
ES506669A0 (en) PROCEDURE FOR OBTAINING A NEW COMPOUND DERIVED FROM P-CHLOROPHENOXYACETIC ACID
PT81314A (en) METHOD FOR OBTAINING ACTIVE THIADIAZOLE DERIVATIVES ON THE CENTRAL NERVOUS SYSTEM
ES8307778A1 (en) 1-Piperazinocarboxylates, process for their preparation and pharmaceutical compositions containing them.
ES517108A0 (en) PROCEDURE FOR THE PREPARATION OF NEW 1-FURIL-3,4-DIHIDROISOQUINOLEINAS.
ES509154A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW ACID DERIVATIVES &amp; -GLUTAMIL-DIAMINOPIMELILO.
KR860008999A (en) Method for preparing N-phenyl-4-phenyl-1-piperazinecarboxamidine
ES498188A0 (en) PROCEDURE FOR THE PREPARATION OF 10-BROMOISOSANDWICINA
ES521080A0 (en) A PROCEDURE FOR PREPARING A PURE ENANTIOMER FROM A SUBSTITUTED ALKAN PHENYLAZINE.
DE3469527D1 (en) Nortropine derivative, process for its preparation and its use
ES546646A0 (en) A PROCEDURE FOR PREPARING AN ARFAMENIN RELATED COMPOUND
DK13985A (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 3-AMINO-4-METHYL-6-PHENYL-PYRIDAZINE DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19970519